Our very own Chief Scientific Officer, Dr. Gregory Leyer will be presenting an evidence-based approach to supporting Heart Health using probiotic superstrain Lactobacillus reuteri NCIMB 30242 or LRC™ at Vitafoods Europe on May 10th at 11:40am. Come hear him speak at the Probiotics Resource Center stand #J139 or visit UAS Labs at our stand: #J133 to learn more about the exciting advancements in probiotics.
- Probiotics, long used to promote gut health, have recently shown impressive data benefiting more distant sites, including heart health.
- LRC™ is unique among probiotics in that it was selected and optimized for a specific activity, namely bile salt hydrolase, to help support heart health.
- The value of the LRC™ approach to strain selection and development is demonstrated in a series of randomized controlled trials showing efficacy, safety and mechanism of action.
About Dr. Greg:
Dr. Gregory Leyer is a world renowned probiotic expert. After receiving his PhD from the University of Wisconsin-Madison in Food Microbiology and Toxicology, Dr. Leyer started his career at Abbott Nutrition in Medical Nutritional Product Development, focusing on innovative probiotic solutions for adults and children. Dr. Leyer then held several positions at Danisco-DuPont Nutrition and Health, including Global Probiotic Technical Director and Global Business Development Director–Consumer Healthcare, all with an emphasis on Probiotics. At UAS Labs, his Chief Scientific Officer responsibilities span leading gold standard clinical trials, quality, regulatory affairs, strategy development, technical service and comprehensive instructional training activities. Dr. Leyer has authored and co-authored several papers in the areas of probiotic clinical results, application know-how, and safety parameters.